Veracyte, Inc.
VCYTDiagnostics & Research
$52.17+3.70%As of Oct 29vs prior close
- Market cap
- $4.2B
- P/E (TTM)
- 36.2×
- P/E (FY1)
- 27.3×
- From 52W high
- −13.75%
- EPS (LTM)
- $1.40
- Revenue (LTM)
- $561.9M
- Net margin
- 20.37%
- Dividend yield
- 0.00%
Nomior Score
66
Steady ProfileSpeculativeTop 15% of the scored universe
Growth51
Quality72
Value61
Momentum60
Resilience57
Growth
+25.90%revenue a year over 9 fiscal years
YE16 $65.1MLTM $561.9M
Connections
Revenue to profitQ2 YE26
17% of revenue became net profit, up 18 pts on a year.
Who owns it
2funds